Compare Heron Therapeutics Inc (HRTX) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs RLX Technology Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while RLX Technology Inc trades at $2.03 (market cap $2.52B). The key difference: RLX Technology Inc is far larger — about 27.6× Heron Therapeutics Inc's market cap, and RLX Technology Inc pays a 4.85% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | RLX | |
|---|---|---|
Market Cap | $91.46M | $2.52B |
Sector | Health | Technology |
52-Week High | $1.96 | $2.73 |
52-Week Low | $0.39 | $1.79 |
Enterprise Value | $189.36M | $1.15B |
Dividend Yield | — | 4.85% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
